nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfasalazine—SLC46A1—Methotrexate—testicular cancer	0.213	0.256	CbGbCtD
Sulfasalazine—PTGS1—Ifosfamide—testicular cancer	0.059	0.0711	CbGbCtD
Sulfasalazine—ABCG2—Dactinomycin—testicular cancer	0.0541	0.0652	CbGbCtD
Sulfasalazine—ABCC2—Carboplatin—testicular cancer	0.0402	0.0485	CbGbCtD
Sulfasalazine—ABCC2—Vinblastine—testicular cancer	0.0375	0.0452	CbGbCtD
Sulfasalazine—ABCG2—Carboplatin—testicular cancer	0.0364	0.0438	CbGbCtD
Sulfasalazine—CYP3A5—Ifosfamide—testicular cancer	0.0354	0.0427	CbGbCtD
Sulfasalazine—ABCC2—Cisplatin—testicular cancer	0.0344	0.0414	CbGbCtD
Sulfasalazine—PTGS2—Cisplatin—testicular cancer	0.034	0.041	CbGbCtD
Sulfasalazine—ABCC2—Etoposide—testicular cancer	0.0338	0.0407	CbGbCtD
Sulfasalazine—PTGS2—Etoposide—testicular cancer	0.0334	0.0402	CbGbCtD
Sulfasalazine—ABCG2—Cisplatin—testicular cancer	0.0311	0.0375	CbGbCtD
Sulfasalazine—ABCG2—Etoposide—testicular cancer	0.0305	0.0368	CbGbCtD
Sulfasalazine—PTGS1—Etoposide—testicular cancer	0.0282	0.034	CbGbCtD
Sulfasalazine—SLCO1B1—Methotrexate—testicular cancer	0.0254	0.0306	CbGbCtD
Sulfasalazine—ABCC2—Doxorubicin—testicular cancer	0.023	0.0278	CbGbCtD
Sulfasalazine—ABCC2—Methotrexate—testicular cancer	0.0223	0.0269	CbGbCtD
Sulfasalazine—ABCG2—Doxorubicin—testicular cancer	0.0208	0.0251	CbGbCtD
Sulfasalazine—ABCG2—Methotrexate—testicular cancer	0.0202	0.0243	CbGbCtD
Sulfasalazine—CYP3A5—Etoposide—testicular cancer	0.0169	0.0204	CbGbCtD
Sulfasalazine—TBXAS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—HPGDS—testicular cancer	0.00979	0.103	CbGpPWpGaD
Sulfasalazine—SLC46A1—seminal vesicle—testicular cancer	0.00442	0.0609	CbGeAlD
Sulfasalazine—ACAT1—gonad—testicular cancer	0.00429	0.0591	CbGeAlD
Sulfasalazine—TBXAS1—Arachidonic acid metabolism—HPGDS—testicular cancer	0.00354	0.0373	CbGpPWpGaD
Sulfasalazine—ACAT1—female gonad—testicular cancer	0.00348	0.048	CbGeAlD
Sulfasalazine—IKBKB—embryo—testicular cancer	0.0032	0.0441	CbGeAlD
Sulfasalazine—ACAT1—testis—testicular cancer	0.00309	0.0426	CbGeAlD
Sulfasalazine—CHUK—Validated transcriptional targets of TAp63 isoforms—TFAP2C—testicular cancer	0.00301	0.0317	CbGpPWpGaD
Sulfasalazine—PPARG—Teniposide—Etoposide—testicular cancer	0.00288	1	CbGdCrCtD
Sulfasalazine—IKBKB—Validated transcriptional targets of TAp63 isoforms—TFAP2C—testicular cancer	0.00273	0.0288	CbGpPWpGaD
Sulfasalazine—SLC7A11—NRF2 pathway—SLC2A6—testicular cancer	0.00266	0.0281	CbGpPWpGaD
Sulfasalazine—CHUK—female gonad—testicular cancer	0.0026	0.0358	CbGeAlD
Sulfasalazine—SLC46A1—female gonad—testicular cancer	0.0026	0.0358	CbGeAlD
Sulfasalazine—TBXAS1—testis—testicular cancer	0.00258	0.0356	CbGeAlD
Sulfasalazine—PLA2G1B—female gonad—testicular cancer	0.00244	0.0336	CbGeAlD
Sulfasalazine—CHUK—testis—testicular cancer	0.0023	0.0317	CbGeAlD
Sulfasalazine—SLC46A1—testis—testicular cancer	0.0023	0.0317	CbGeAlD
Sulfasalazine—ACAT1—lymph node—testicular cancer	0.00224	0.0309	CbGeAlD
Sulfasalazine—CHUK—Canonical NF-kappaB pathway—BCL10—testicular cancer	0.00221	0.0232	CbGpPWpGaD
Sulfasalazine—CHUK—FCERI mediated NF-kB activation—BCL10—testicular cancer	0.00221	0.0232	CbGpPWpGaD
Sulfasalazine—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—HPGDS—testicular cancer	0.0022	0.0231	CbGpPWpGaD
Sulfasalazine—IKBKB—gonad—testicular cancer	0.00217	0.0299	CbGeAlD
Sulfasalazine—PLA2G1B—testis—testicular cancer	0.00216	0.0298	CbGeAlD
Sulfasalazine—SLC7A11—female gonad—testicular cancer	0.00214	0.0295	CbGeAlD
Sulfasalazine—IKBKB—FCERI mediated NF-kB activation—BCL10—testicular cancer	0.002	0.0211	CbGpPWpGaD
Sulfasalazine—IKBKB—Canonical NF-kappaB pathway—BCL10—testicular cancer	0.002	0.0211	CbGpPWpGaD
Sulfasalazine—PPARG—embryo—testicular cancer	0.00199	0.0274	CbGeAlD
Sulfasalazine—SLC7A11—testis—testicular cancer	0.0019	0.0261	CbGeAlD
Sulfasalazine—TBXAS1—lymph node—testicular cancer	0.00187	0.0258	CbGeAlD
Sulfasalazine—ALOX5—Arachidonic acid metabolism—HPGDS—testicular cancer	0.00183	0.0193	CbGpPWpGaD
Sulfasalazine—IKBKB—female gonad—testicular cancer	0.00176	0.0243	CbGeAlD
Sulfasalazine—PTGS2—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—HPGDS—testicular cancer	0.00174	0.0184	CbGpPWpGaD
Sulfasalazine—SLC7A11—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.00168	0.0177	CbGpPWpGaD
Sulfasalazine—CHUK—lymph node—testicular cancer	0.00167	0.023	CbGeAlD
Sulfasalazine—SLC46A1—lymph node—testicular cancer	0.00167	0.023	CbGeAlD
Sulfasalazine—IKBKB—testis—testicular cancer	0.00157	0.0216	CbGeAlD
Sulfasalazine—ALOX5—female gonad—testicular cancer	0.00146	0.0202	CbGeAlD
Sulfasalazine—CHUK—Downstream TCR signaling—BCL10—testicular cancer	0.00139	0.0146	CbGpPWpGaD
Sulfasalazine—TBXAS1—Biological oxidations—HPGDS—testicular cancer	0.00132	0.0139	CbGpPWpGaD
Sulfasalazine—ALOX5—testis—testicular cancer	0.0013	0.0179	CbGeAlD
Sulfasalazine—IKBKB—Downstream TCR signaling—BCL10—testicular cancer	0.00126	0.0133	CbGpPWpGaD
Sulfasalazine—ABCG2—seminal vesicle—testicular cancer	0.0012	0.0165	CbGeAlD
Sulfasalazine—SLC46A1—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.00116	0.0122	CbGpPWpGaD
Sulfasalazine—IKBKB—lymph node—testicular cancer	0.00113	0.0156	CbGeAlD
Sulfasalazine—CHUK—TCR signaling in naïve CD8+ T cells—BCL10—testicular cancer	0.00113	0.0119	CbGpPWpGaD
Sulfasalazine—ABCC2—NRF2 pathway—SLC2A6—testicular cancer	0.00111	0.0117	CbGpPWpGaD
Sulfasalazine—PPARG—female gonad—testicular cancer	0.0011	0.0151	CbGeAlD
Sulfasalazine—CHUK—TCR signaling—BCL10—testicular cancer	0.00104	0.0109	CbGpPWpGaD
Sulfasalazine—IKBKB—TCR signaling in naïve CD8+ T cells—BCL10—testicular cancer	0.00103	0.0108	CbGpPWpGaD
Sulfasalazine—PTGS2—embryo—testicular cancer	0.00102	0.014	CbGeAlD
Sulfasalazine—PTGS1—seminal vesicle—testicular cancer	0.001	0.0138	CbGeAlD
Sulfasalazine—PPARG—testis—testicular cancer	0.000974	0.0134	CbGeAlD
Sulfasalazine—CHUK—Activation of NF-kappaB in B cells—BCL10—testicular cancer	0.000961	0.0101	CbGpPWpGaD
Sulfasalazine—PTGS2—seminal vesicle—testicular cancer	0.000956	0.0132	CbGeAlD
Sulfasalazine—CHUK—TCR signaling in naïve CD4+ T cells—BCL10—testicular cancer	0.000949	0.01	CbGpPWpGaD
Sulfasalazine—IKBKB—TCR signaling—BCL10—testicular cancer	0.000941	0.00992	CbGpPWpGaD
Sulfasalazine—ALOX5—lymph node—testicular cancer	0.00094	0.013	CbGeAlD
Sulfasalazine—CHUK—BCR signaling pathway—BCL10—testicular cancer	0.000938	0.00988	CbGpPWpGaD
Sulfasalazine—IKBKB—Activation of NF-kappaB in B cells—BCL10—testicular cancer	0.000871	0.00918	CbGpPWpGaD
Sulfasalazine—IKBKB—TCR signaling in naïve CD4+ T cells—BCL10—testicular cancer	0.000861	0.00907	CbGpPWpGaD
Sulfasalazine—ABCC2—testis—testicular cancer	0.000856	0.0118	CbGeAlD
Sulfasalazine—SLC7A11—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000853	0.00899	CbGpPWpGaD
Sulfasalazine—IKBKB—BCR signaling pathway—BCL10—testicular cancer	0.00085	0.00896	CbGpPWpGaD
Sulfasalazine—PTGS1—Arachidonic acid metabolism—HPGDS—testicular cancer	0.000793	0.00836	CbGpPWpGaD
Sulfasalazine—CHUK—TCR Signaling Pathway—BCL10—testicular cancer	0.000741	0.00781	CbGpPWpGaD
Sulfasalazine—PPARG—lymph node—testicular cancer	0.000706	0.00973	CbGeAlD
Sulfasalazine—ABCG2—female gonad—testicular cancer	0.000704	0.0097	CbGeAlD
Sulfasalazine—CHUK—B Cell Receptor Signaling Pathway—BCL10—testicular cancer	0.000698	0.00735	CbGpPWpGaD
Sulfasalazine—PTGS2—Aryl Hydrocarbon Receptor—HPGDS—testicular cancer	0.000673	0.00709	CbGpPWpGaD
Sulfasalazine—IKBKB—TCR Signaling Pathway—BCL10—testicular cancer	0.000672	0.00708	CbGpPWpGaD
Sulfasalazine—ACAT1—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	0.000667	0.00703	CbGpPWpGaD
Sulfasalazine—SLCO1B1—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.000657	0.00692	CbGpPWpGaD
Sulfasalazine—CYP3A5—female gonad—testicular cancer	0.000653	0.00901	CbGeAlD
Sulfasalazine—CHUK—Osteopontin-mediated events—MMP2—testicular cancer	0.000633	0.00668	CbGpPWpGaD
Sulfasalazine—IKBKB—B Cell Receptor Signaling Pathway—BCL10—testicular cancer	0.000632	0.00667	CbGpPWpGaD
Sulfasalazine—PTGS2—Arachidonic acid metabolism—HPGDS—testicular cancer	0.00063	0.00664	CbGpPWpGaD
Sulfasalazine—ABCG2—testis—testicular cancer	0.000624	0.00861	CbGeAlD
Sulfasalazine—ABCC2—lymph node—testicular cancer	0.000621	0.00855	CbGeAlD
Sulfasalazine—PPARG—Developmental Biology—PRDM14—testicular cancer	0.000612	0.00645	CbGpPWpGaD
Sulfasalazine—PTGS1—female gonad—testicular cancer	0.000587	0.00809	CbGeAlD
Sulfasalazine—PTGS2—female gonad—testicular cancer	0.000561	0.00773	CbGeAlD
Sulfasalazine—PTGS1—testis—testicular cancer	0.000521	0.00718	CbGeAlD
Sulfasalazine—TBXAS1—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	0.000506	0.00533	CbGpPWpGaD
Sulfasalazine—CHUK—Constitutive PI3K/AKT Signaling in Cancer—KITLG—testicular cancer	0.000463	0.00488	CbGpPWpGaD
Sulfasalazine—ABCG2—lymph node—testicular cancer	0.000453	0.00624	CbGeAlD
Sulfasalazine—CHUK—Downstream signaling events of B Cell Receptor (BCR)—BCL10—testicular cancer	0.000452	0.00476	CbGpPWpGaD
Sulfasalazine—PTGS2—C-MYB transcription factor network—MAD1L1—testicular cancer	0.000436	0.00459	CbGpPWpGaD
Sulfasalazine—CHUK—Fc epsilon receptor (FCERI) signaling—BCL10—testicular cancer	0.000431	0.00454	CbGpPWpGaD
Sulfasalazine—CHUK—PI-3K cascade—KITLG—testicular cancer	0.000417	0.0044	CbGpPWpGaD
Sulfasalazine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—BCL10—testicular cancer	0.00041	0.00432	CbGpPWpGaD
Sulfasalazine—CHUK—PI3K/AKT activation—KITLG—testicular cancer	0.000407	0.00429	CbGpPWpGaD
Sulfasalazine—CHUK—GAB1 signalosome—KITLG—testicular cancer	0.000404	0.00426	CbGpPWpGaD
Sulfasalazine—CHUK—B Cell Activation—BCL10—testicular cancer	0.000399	0.0042	CbGpPWpGaD
Sulfasalazine—CHUK—Role of LAT2/NTAL/LAB on calcium mobilization—KITLG—testicular cancer	0.000395	0.00416	CbGpPWpGaD
Sulfasalazine—IKBKB—Fc epsilon receptor (FCERI) signaling—BCL10—testicular cancer	0.000391	0.00412	CbGpPWpGaD
Sulfasalazine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—testicular cancer	0.000385	0.00406	CbGpPWpGaD
Sulfasalazine—PTGS1—lymph node—testicular cancer	0.000377	0.0052	CbGeAlD
Sulfasalazine—PLA2G1B—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	0.000369	0.00389	CbGpPWpGaD
Sulfasalazine—CHUK—Integrated Pancreatic Cancer Pathway—HPGDS—testicular cancer	0.000364	0.00383	CbGpPWpGaD
Sulfasalazine—IKBKB—B Cell Activation—BCL10—testicular cancer	0.000362	0.00381	CbGpPWpGaD
Sulfasalazine—PTGS2—lymph node—testicular cancer	0.000361	0.00497	CbGeAlD
Sulfasalazine—ABCC2—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000355	0.00375	CbGpPWpGaD
Sulfasalazine—CHUK—AGE/RAGE pathway—MMP2—testicular cancer	0.000346	0.00365	CbGpPWpGaD
Sulfasalazine—CHUK—Constitutive PI3K/AKT Signaling in Cancer—FGFR3—testicular cancer	0.000344	0.00363	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000334	0.00352	CbGpPWpGaD
Sulfasalazine—CHUK—Integrated Breast Cancer Pathway—STK11—testicular cancer	0.000319	0.00336	CbGpPWpGaD
Sulfasalazine—CHUK—Constitutive PI3K/AKT Signaling in Cancer—KIT—testicular cancer	0.000316	0.00333	CbGpPWpGaD
Sulfasalazine—IKBKB—AGE/RAGE pathway—MMP2—testicular cancer	0.000314	0.00331	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by SCF-KIT—KITLG—testicular cancer	0.000312	0.00329	CbGpPWpGaD
Sulfasalazine—CHUK—PI-3K cascade—FGFR3—testicular cancer	0.00031	0.00327	CbGpPWpGaD
Sulfasalazine—ABCG2—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000309	0.00326	CbGpPWpGaD
Sulfasalazine—PTGS2—C-MYB transcription factor network—H2AFZ—testicular cancer	0.000304	0.0032	CbGpPWpGaD
Sulfasalazine—CHUK—PI3K/AKT activation—FGFR3—testicular cancer	0.000303	0.00319	CbGpPWpGaD
Sulfasalazine—CHUK—GAB1 signalosome—FGFR3—testicular cancer	0.0003	0.00316	CbGpPWpGaD
Sulfasalazine—CHUK—Downstream signaling of activated FGFR—KITLG—testicular cancer	0.000298	0.00314	CbGpPWpGaD
Sulfasalazine—ACAT1—Metabolism—HPGDS—testicular cancer	0.000297	0.00313	CbGpPWpGaD
Sulfasalazine—PTGS1—Biological oxidations—HPGDS—testicular cancer	0.000295	0.00311	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by ERBB4—KITLG—testicular cancer	0.000294	0.00309	CbGpPWpGaD
Sulfasalazine—CHUK—Role of LAT2/NTAL/LAB on calcium mobilization—FGFR3—testicular cancer	0.000293	0.00309	CbGpPWpGaD
Sulfasalazine—CHUK—PI-3K cascade—KIT—testicular cancer	0.000285	0.003	CbGpPWpGaD
Sulfasalazine—CHUK—Downstream signal transduction—KITLG—testicular cancer	0.00028	0.00296	CbGpPWpGaD
Sulfasalazine—PTGS2—C-MYB transcription factor network—KITLG—testicular cancer	0.00028	0.00295	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by FGFR—KITLG—testicular cancer	0.000279	0.00294	CbGpPWpGaD
Sulfasalazine—CHUK—PI3K/AKT activation—KIT—testicular cancer	0.000278	0.00293	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by ERBB2—KITLG—testicular cancer	0.000278	0.00293	CbGpPWpGaD
Sulfasalazine—CHUK—DAP12 signaling—KITLG—testicular cancer	0.000276	0.00291	CbGpPWpGaD
Sulfasalazine—CHUK—GAB1 signalosome—KIT—testicular cancer	0.000276	0.00291	CbGpPWpGaD
Sulfasalazine—CHUK—Downstream signaling events of B Cell Receptor (BCR)—KITLG—testicular cancer	0.000272	0.00287	CbGpPWpGaD
Sulfasalazine—CHUK—Role of LAT2/NTAL/LAB on calcium mobilization—KIT—testicular cancer	0.000269	0.00284	CbGpPWpGaD
Sulfasalazine—CHUK—Integrated Pancreatic Cancer Pathway—STK11—testicular cancer	0.000264	0.00279	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	0.000261	0.00276	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by FGFR in disease—KITLG—testicular cancer	0.00026	0.00274	CbGpPWpGaD
Sulfasalazine—CHUK—DAP12 interactions—KITLG—testicular cancer	0.00026	0.00274	CbGpPWpGaD
Sulfasalazine—CHUK—Fc epsilon receptor (FCERI) signaling—KITLG—testicular cancer	0.00026	0.00274	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by EGFR—KITLG—testicular cancer	0.000258	0.00272	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by EGFR in Cancer—KITLG—testicular cancer	0.000255	0.00269	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by PDGF—KITLG—testicular cancer	0.000254	0.00268	CbGpPWpGaD
Sulfasalazine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—KITLG—testicular cancer	0.000247	0.0026	CbGpPWpGaD
Sulfasalazine—CHUK—B Cell Activation—KITLG—testicular cancer	0.000241	0.00254	CbGpPWpGaD
Sulfasalazine—IKBKB—Fc epsilon receptor (FCERI) signaling—KITLG—testicular cancer	0.000236	0.00248	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by SCF-KIT—FGFR3—testicular cancer	0.000232	0.00244	CbGpPWpGaD
Sulfasalazine—CHUK—NGF signalling via TRKA from the plasma membrane—KITLG—testicular cancer	0.00023	0.00243	CbGpPWpGaD
Sulfasalazine—TBXAS1—Metabolism—HPGDS—testicular cancer	0.000225	0.00237	CbGpPWpGaD
Sulfasalazine—CHUK—Downstream signaling of activated FGFR—FGFR3—testicular cancer	0.000222	0.00234	CbGpPWpGaD
Sulfasalazine—CYP3A5—Biological oxidations—HPGDS—testicular cancer	0.00022	0.00232	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by ERBB4—FGFR3—testicular cancer	0.000218	0.0023	CbGpPWpGaD
Sulfasalazine—IKBKB—B Cell Activation—KITLG—testicular cancer	0.000218	0.0023	CbGpPWpGaD
Sulfasalazine—ACAT1—Metabolism—STK11—testicular cancer	0.000216	0.00228	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—HPGDS—testicular cancer	0.000216	0.00227	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by SCF-KIT—KIT—testicular cancer	0.000213	0.00224	CbGpPWpGaD
Sulfasalazine—CHUK—Downstream signal transduction—FGFR3—testicular cancer	0.000208	0.0022	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by FGFR—FGFR3—testicular cancer	0.000207	0.00219	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by ERBB2—FGFR3—testicular cancer	0.000206	0.00217	CbGpPWpGaD
Sulfasalazine—CHUK—DAP12 signaling—FGFR3—testicular cancer	0.000205	0.00216	CbGpPWpGaD
Sulfasalazine—CHUK—Downstream signaling of activated FGFR—KIT—testicular cancer	0.000204	0.00215	CbGpPWpGaD
Sulfasalazine—CHUK—Downstream signaling events of B Cell Receptor (BCR)—FGFR3—testicular cancer	0.000202	0.00213	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by ERBB4—KIT—testicular cancer	0.0002	0.00211	CbGpPWpGaD
Sulfasalazine—SLC46A1—Metabolism—HPGDS—testicular cancer	0.000197	0.00207	CbGpPWpGaD
Sulfasalazine—PPARG—Gene Expression—DNMT3L—testicular cancer	0.000194	0.00204	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by FGFR in disease—FGFR3—testicular cancer	0.000193	0.00204	CbGpPWpGaD
Sulfasalazine—CHUK—DAP12 interactions—FGFR3—testicular cancer	0.000193	0.00204	CbGpPWpGaD
Sulfasalazine—CHUK—Fc epsilon receptor (FCERI) signaling—FGFR3—testicular cancer	0.000193	0.00204	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by EGFR—FGFR3—testicular cancer	0.000191	0.00202	CbGpPWpGaD
Sulfasalazine—CHUK—Downstream signal transduction—KIT—testicular cancer	0.000191	0.00202	CbGpPWpGaD
Sulfasalazine—PTGS2—C-MYB transcription factor network—KIT—testicular cancer	0.000191	0.00201	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by FGFR—KIT—testicular cancer	0.00019	0.00201	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by EGFR in Cancer—FGFR3—testicular cancer	0.00019	0.002	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by ERBB2—KIT—testicular cancer	0.000189	0.002	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by PDGF—FGFR3—testicular cancer	0.000189	0.00199	CbGpPWpGaD
Sulfasalazine—CHUK—DAP12 signaling—KIT—testicular cancer	0.000189	0.00199	CbGpPWpGaD
Sulfasalazine—CHUK—Downstream signaling events of B Cell Receptor (BCR)—KIT—testicular cancer	0.000186	0.00196	CbGpPWpGaD
Sulfasalazine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—FGFR3—testicular cancer	0.000184	0.00193	CbGpPWpGaD
Sulfasalazine—CHUK—B Cell Activation—FGFR3—testicular cancer	0.000179	0.00188	CbGpPWpGaD
Sulfasalazine—CHUK—DAP12 interactions—KIT—testicular cancer	0.000177	0.00187	CbGpPWpGaD
Sulfasalazine—CHUK—Fc epsilon receptor (FCERI) signaling—KIT—testicular cancer	0.000177	0.00187	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by FGFR in disease—KIT—testicular cancer	0.000177	0.00187	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by NGF—KITLG—testicular cancer	0.000177	0.00187	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by EGFR—KIT—testicular cancer	0.000176	0.00185	CbGpPWpGaD
Sulfasalazine—IKBKB—Fc epsilon receptor (FCERI) signaling—FGFR3—testicular cancer	0.000175	0.00185	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by EGFR in Cancer—KIT—testicular cancer	0.000174	0.00184	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by PDGF—KIT—testicular cancer	0.000173	0.00183	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—H2AFZ—testicular cancer	0.000172	0.00181	CbGpPWpGaD
Sulfasalazine—CHUK—NGF signalling via TRKA from the plasma membrane—FGFR3—testicular cancer	0.000171	0.0018	CbGpPWpGaD
Sulfasalazine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—KIT—testicular cancer	0.000169	0.00178	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—BCL10—testicular cancer	0.000168	0.00177	CbGpPWpGaD
Sulfasalazine—PLA2G1B—Metabolism—HPGDS—testicular cancer	0.000164	0.00173	CbGpPWpGaD
Sulfasalazine—CHUK—B Cell Activation—KIT—testicular cancer	0.000164	0.00173	CbGpPWpGaD
Sulfasalazine—TBXAS1—Metabolism—STK11—testicular cancer	0.000164	0.00172	CbGpPWpGaD
Sulfasalazine—IKBKB—B Cell Activation—FGFR3—testicular cancer	0.000162	0.00171	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	0.000162	0.00171	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—BCL10—testicular cancer	0.000161	0.0017	CbGpPWpGaD
Sulfasalazine—IKBKB—Fc epsilon receptor (FCERI) signaling—KIT—testicular cancer	0.000161	0.0017	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling by NGF—KITLG—testicular cancer	0.000161	0.00169	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—KITLG—testicular cancer	0.000158	0.00167	CbGpPWpGaD
Sulfasalazine—CHUK—NGF signalling via TRKA from the plasma membrane—KIT—testicular cancer	0.000157	0.00166	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—STK11—testicular cancer	0.000157	0.00165	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—BCL10—testicular cancer	0.000152	0.0016	CbGpPWpGaD
Sulfasalazine—IKBKB—B Cell Activation—KIT—testicular cancer	0.000149	0.00157	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—BCL10—testicular cancer	0.000146	0.00154	CbGpPWpGaD
Sulfasalazine—SLC46A1—Metabolism—STK11—testicular cancer	0.000143	0.00151	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by NGF—FGFR3—testicular cancer	0.000132	0.00139	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—INSL3—testicular cancer	0.000129	0.00136	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	0.000127	0.00134	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by NGF—KIT—testicular cancer	0.000121	0.00127	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling by NGF—FGFR3—testicular cancer	0.000119	0.00126	CbGpPWpGaD
Sulfasalazine—PLA2G1B—Metabolism—STK11—testicular cancer	0.000119	0.00126	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—FGFR3—testicular cancer	0.000117	0.00124	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—INSL3—testicular cancer	0.000117	0.00123	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism—HPGDS—testicular cancer	0.000116	0.00123	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	0.000113	0.00119	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling by NGF—KIT—testicular cancer	0.00011	0.00115	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—KIT—testicular cancer	0.000108	0.00114	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—KITLG—testicular cancer	0.000101	0.00106	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—BCL10—testicular cancer	9.76e-05	0.00103	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—KITLG—testicular cancer	9.7e-05	0.00102	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—KITLG—testicular cancer	9.16e-05	0.000965	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	9e-05	0.000948	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—BCL10—testicular cancer	8.85e-05	0.000932	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—KITLG—testicular cancer	8.79e-05	0.000927	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism—STK11—testicular cancer	8.46e-05	0.000892	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—FGFR3—testicular cancer	7.51e-05	0.000791	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—MMP2—testicular cancer	7.37e-05	0.000776	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—FGFR3—testicular cancer	7.21e-05	0.00076	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—HPGDS—testicular cancer	7.21e-05	0.00076	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—KIT—testicular cancer	6.89e-05	0.000726	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—FGFR3—testicular cancer	6.81e-05	0.000717	CbGpPWpGaD
Sulfasalazine—PPARG—Gene Expression—H2AFZ—testicular cancer	6.77e-05	0.000714	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—KIT—testicular cancer	6.62e-05	0.000698	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—FGFR3—testicular cancer	6.54e-05	0.000689	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—KIT—testicular cancer	6.25e-05	0.000659	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—KIT—testicular cancer	6e-05	0.000632	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—H2AFZ—testicular cancer	5.9e-05	0.000622	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—KITLG—testicular cancer	5.88e-05	0.00062	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—HPGDS—testicular cancer	5.68e-05	0.000598	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—KITLG—testicular cancer	5.43e-05	0.000572	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—KITLG—testicular cancer	5.33e-05	0.000562	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—HPGDS—testicular cancer	5.26e-05	0.000554	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—STK11—testicular cancer	5.24e-05	0.000552	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—HPGDS—testicular cancer	5.05e-05	0.000532	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—FGFR3—testicular cancer	4.37e-05	0.000461	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—H2AFZ—testicular cancer	4.13e-05	0.000436	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—STK11—testicular cancer	4.12e-05	0.000435	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—STK11—testicular cancer	4.11e-05	0.000433	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—FGFR3—testicular cancer	4.04e-05	0.000425	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—KIT—testicular cancer	4.01e-05	0.000423	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—HPGDS—testicular cancer	4.01e-05	0.000422	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—FGFR3—testicular cancer	3.96e-05	0.000418	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—STK11—testicular cancer	3.82e-05	0.000402	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—KITLG—testicular cancer	3.8e-05	0.000401	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—HPGDS—testicular cancer	3.77e-05	0.000397	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—H2AFZ—testicular cancer	3.75e-05	0.000395	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—STK11—testicular cancer	3.73e-05	0.000393	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—KIT—testicular cancer	3.71e-05	0.000391	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—STK11—testicular cancer	3.67e-05	0.000387	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—KIT—testicular cancer	3.64e-05	0.000384	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—H2AFZ—testicular cancer	3.5e-05	0.000369	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—KITLG—testicular cancer	3.45e-05	0.000363	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—KITLG—testicular cancer	3.22e-05	0.000339	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—STK11—testicular cancer	2.91e-05	0.000307	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—FGFR3—testicular cancer	2.83e-05	0.000298	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—STK11—testicular cancer	2.74e-05	0.000288	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—KIT—testicular cancer	2.6e-05	0.000274	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—FGFR3—testicular cancer	2.56e-05	0.00027	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—FGFR3—testicular cancer	2.39e-05	0.000252	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—KIT—testicular cancer	2.35e-05	0.000248	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—KIT—testicular cancer	2.2e-05	0.000231	CbGpPWpGaD
